Trending Stock News

Wix.com Ltd. (WIX) Reaches $76.10 After 7.00% Down Move; 5 Analysts Are Bullish Ligand Pharmaceuticals (LGND) Last Week

Among 6 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Ligand Pharmaceuticals had 24 analyst reports since September 3, 2015 according to SRatingsIntel. The rating was maintained by Roth Capital with “Buy” on Thursday, September 3. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) earned “Sell” rating by Deutsche Bank on Monday, November 20. The firm has “Hold” rating given on Monday, July 17 by Deutsche Bank. On Monday, September 21 the stock rating was maintained by Roth Capital with “Buy”. The rating was maintained by TH Capital on Friday, December 18 with “Buy”. The company was maintained on Thursday, October 5 by H.C. Wainwright. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has “Buy” rating given on Friday, March 11 by Roth Capital. On Thursday, November 19 the stock rating was maintained by Roth Capital with “Buy”. The company was initiated on Wednesday, April 13 by Stephens. The firm earned “Buy” rating on Monday, November 13 by Roth Capital. See Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) latest ratings:

24/01/2018 Broker: H.C. Wainwright Old Rating: Buy New Rating: Buy Old Target: $159 New Target: $170 Maintain
20/11/2017 Broker: Deutsche Bank Old Rating: Hold New Rating: Sell Old Target: $104 Downgrade
15/11/2017 Broker: Craig Hallum Rating: Buy New Target: $170.0 Maintain
13/11/2017 Broker: Roth Capital Rating: Buy New Target: $158.0 Maintain
09/11/2017 Broker: H.C. Wainwright Rating: Buy Old Target: $157 New Target: $159 Maintain
18/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $157.0 Maintain
11/10/2017 Broker: Roth Capital Rating: Buy New Target: $158.0 Maintain
05/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $157.0 Maintain
05/09/2017 Broker: H.C. Wainwright Rating: Buy New Target: $150 Reinitiate

The stock of Wix.com Ltd. (NASDAQ:WIX) is a huge mover today! The stock decreased 1.55% or $1.2 during the last trading session, reaching $76.1. About 240,067 shares traded. Wix.com Ltd. (NASDAQ:WIX) has risen 188.42% since February 22, 2017 and is uptrending. It has outperformed by 171.72% the S&P500.The move comes after 8 months negative chart setup for the $3.46B company. It was reported on Feb, 22 by Barchart.com. We have $70.77 PT which if reached, will make NASDAQ:WIX worth $242.13M less.

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company has market cap of $3.29 billion. The Company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis and Evomela, which are used to treat multiple myeloma; CorMatrix portfolio of vascular, cardiac, and pericardial tissue repair products; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Carnexiv that is used as replacement therapy for oral carbamazepine formulations; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer. It has a 199.28 P/E ratio. The companyÂ’s partners programs, which are in clinical development used for the treatment of seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, kidney disease, and others.

Since August 23, 2017, it had 0 buys, and 6 sales for $10.58 million activity. $3.71M worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) was sold by HIGGINS JOHN L on Wednesday, January 24. Aryeh Jason sold $255,980 worth of stock or 2,000 shares. The insider KOZARICH JOHN W sold 2,500 shares worth $362,500. Shares for $126,956 were sold by Sabba Stephen L on Wednesday, December 20.

The stock decreased 0.45% or $0.7 during the last trading session, reaching $155.64. About 75,149 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has declined 2.87% since February 22, 2017 and is downtrending. It has underperformed by 19.57% the S&P500.

Investors sentiment increased to 1.69 in 2017 Q3. Its up 0.45, from 1.24 in 2017Q2. It increased, as 19 investors sold Ligand Pharmaceuticals Incorporated shares while 68 reduced holdings. 50 funds opened positions while 97 raised stakes. 22.76 million shares or 0.86% more from 22.57 million shares in 2017Q2 were reported. Adams Diversified Equity Fund holds 0.04% or 4,900 shares in its portfolio. Alpine Woods Cap Investors Ltd owns 3,284 shares. Comerica Natl Bank stated it has 26,531 shares. Public Employees Retirement System Of Ohio has invested 0.03% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Howe & Rusling owns 0.03% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 1,335 shares. Lpl Llc holds 0% or 4,237 shares. Alps stated it has 20,603 shares or 0.02% of all its holdings. Pinebridge Ltd Partnership has 0.01% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Spectrum Gru holds 3 shares or 0% of its portfolio. Assetmark holds 242 shares or 0% of its portfolio. Opus Point Ptnrs Management Limited Co holds 0.19% or 1,519 shares. Janney Montgomery Scott Limited Liability Corporation reported 28,329 shares stake. Moreover, Rice Hall James And Assocs Ltd Liability Corporation has 1.61% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 268,014 shares. Putnam Investments Ltd stated it has 19,772 shares or 0.01% of all its holdings. Gemmer Asset Management Lc holds 0% or 53 shares in its portfolio.

Wix.com Ltd. develops and markets an Internet service that allows users to create Web content in Latin America, Europe, North America, Asia, and internationally. The company has market cap of $3.46 billion. It offers Web development, design, and management solutions and apps through an online platform that enables its user base of businesses, organizations, professionals, and individuals to create a digital presence. It currently has negative earnings. The companyÂ’s principal product is the Wix Editor, a drag-and-drop visual development and Website editing environment.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.15, from 0.81 in 2017Q2. It is positive, as 37 investors sold Wix.com Ltd. shares while 35 reduced holdings. 18 funds opened positions while 51 raised stakes. 34.13 million shares or 14.13% more from 29.90 million shares in 2017Q2 were reported. Oak Ridge Invs Ltd Liability Com reported 178,819 shares or 0.52% of all its holdings. 269,837 were accumulated by Ion Asset Mngmt Ltd. 22,879 were reported by Hbk Invs Lp. Pacad Inv Limited holds 2,950 shares or 0.05% of its portfolio. California Public Employees Retirement Sys has invested 0% in Wix.com Ltd. (NASDAQ:WIX). Bnp Paribas Arbitrage holds 10,370 shares or 0% of its portfolio. The New York-based Davidson Kempner Cap Mngmt L P has invested 0.32% in Wix.com Ltd. (NASDAQ:WIX). Schroder Investment Mngmt Grp Incorporated reported 45,058 shares. Pnc Financial Services Group Inc holds 522 shares. Lord Abbett & Llc owns 288,450 shares. Prelude Cap Mngmt Ltd has invested 0.38% of its portfolio in Wix.com Ltd. (NASDAQ:WIX). Gsa Llp has invested 0.02% in Wix.com Ltd. (NASDAQ:WIX). Frontier Capital Management Comm Limited Liability Corp owns 223,674 shares. 420,000 were reported by Ems Cap L P. Moreover, Grandeur Peak Ltd Limited Liability Company has 3.25% invested in Wix.com Ltd. (NASDAQ:WIX) for 296,100 shares.

Analysts await Wix.com Ltd. (NASDAQ:WIX) to report earnings on May, 9. They expect $-0.39 earnings per share, up 17.02% or $0.08 from last year’s $-0.47 per share. After $-0.08 actual earnings per share reported by Wix.com Ltd. for the previous quarter, Wall Street now forecasts 387.50% negative EPS growth.

Among 14 analysts covering Wix.com (NASDAQ:WIX), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. Wix.com had 35 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Wednesday, September 21 by JP Morgan. The stock has “Market Perform” rating by Raymond James on Thursday, April 13. The rating was upgraded by Raymond James to “Buy” on Thursday, January 4. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, September 23. The firm has “Neutral” rating given on Tuesday, April 11 by Cantor Fitzgerald. The rating was maintained by RBC Capital Markets on Thursday, July 27 with “Hold”. As per Thursday, November 9, the company rating was maintained by KeyBanc Capital Markets. Wedbush downgraded Wix.com Ltd. (NASDAQ:WIX) on Thursday, November 9 to “Neutral” rating. The stock has “Buy” rating by Oppenheimer on Wednesday, August 9. Deutsche Bank upgraded the shares of WIX in report on Wednesday, September 2 to “Buy” rating.

Leave a Reply

Your email address will not be published. Required fields are marked *